How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease

BACKGROUND: Acute rheumatic fever (ARF) and rheumatic heart disease cause substantial burdens worldwide. Long‐term antibiotic secondary prophylaxis is used to prevent disease progression, but evidence for benefits of different adherence levels is limited. Using data from northern Australia, we ident...

Descripción completa

Detalles Bibliográficos
Autores principales: de Dassel, Jessica Langloh, de Klerk, Nick, Carapetis, Jonathan Rhys, Ralph, Anna P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405600/
https://www.ncbi.nlm.nih.gov/pubmed/30561268
http://dx.doi.org/10.1161/JAHA.118.010223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405600/
https://www.ncbi.nlm.nih.gov/pubmed/30561268
http://dx.doi.org/10.1161/JAHA.118.010223

Ejemplares similares